Homocysteine lowering: any use in atherosclerosis?

Homocysteine lowering: any use in atherosclerosis?

Bibliográfalaš dieđut
Váldodahkkit:	Antoniades, C, Shirodaria, C, Stefanadis, C, Channon, K
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2007

Geahča maid

Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2009)

MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2009)

Vascular Homocysteine Versus 5-Methyl-Tetrahydrofolate As Regulators of Vascular Redox and Endothelial Function in Human Vessels
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2009)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2010)

Plasma levels of sCD40-ligand interact with homocysteine biosynthetic pathway and predict eNOS coupling in human vessels: effects on vascular redox state
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2008)

Soluble CD40-ligand levels are associated with vascular superoxide production and eNOS coupling in human vessels: Interrelationships with homocysteine biosynthetic pathway
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2008)

Serum adiponectin regulates vascular O2-generation and NO bioavailability in patients with coronary atherosclerosis
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2010)

Genetic variation in GCH1, encoding GTP-cyclohydrolase 1, regulates biopterin levels and endothelial function in atherosclerosis
Dahkki: Van, A, et al.
Almmustuhtton: (2008)

Associations Between Serum Adiponectin, Vascular O2-Generation and NO Bioavailability In Patients With Coronary Atherosclerosis
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2010)

Homocysteine: a risk factor for coronary artery disease?
Dahkki: Marinou, K, et al.
Almmustuhtton: (2005)

OCT characteristics of saphenous vein graft atherosclerosis.
Dahkki: Adlam, D, et al.
Almmustuhtton: (2011)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2011)

Vascular Homocysteine vs 5-Methyl-Tetrahydrofolate as Regulators of Vascular Redox and Endothelial Function in Human Vessels
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2008)

The oxidative stress menace to coronary vasculature: any place for antioxidants?
Dahkki: Briasoulis, A, et al.
Almmustuhtton: (2009)

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2009)

Is vascular superoxide triggering adiponectin biosynthesis in perivascular adipose tissue in patients with atherosclerosis?
Dahkki: Bakogiannis, C, et al.
Almmustuhtton: (2010)

Biomarkers of premature atherosclerosis.
Dahkki: Kampoli, A, et al.
Almmustuhtton: (2009)

Response to Asymmetrical Dimethylarginine, Oxidative Stress, and Atherosclerosis
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2011)

Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2007)

Altered plasma vs. vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function and inflammation
Dahkki: Antomades, C, et al.
Almmustuhtton: (2007)

Statins ameliorate atherosclerosis induced by inhibition of nitric oxide synthase: another novel vascular protective mechanism?
Dahkki: Tousoulis, D, et al.
Almmustuhtton: (2008)

Letter by Antoniades et al regarding article, "Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction".
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2010)

Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus.
Dahkki: Lee, J, et al.
Almmustuhtton: (2007)

Pathophysiology of atherosclerosis: the role of inflammation.
Dahkki: Tousoulis, D, et al.
Almmustuhtton: (2011)

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
Dahkki: Bakogiannis, C, et al.
Almmustuhtton: (2010)

Relationships between vascular/plasma biopterins and endothelial nitric oxide synthase coupling, endothelial function and inflammation, in human atherosclerosis
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2008)

NADPH-oxidase activity in peripheral blood mononuclear cells as a novel inflammatory marker in atherosclerosis
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2010)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
Dahkki: Antonopoulos, A, et al.
Almmustuhtton: (2010)

Effects of endothelial nitric oxide synthase gene polymorphisms on oxidative stress, inflammatory status, and coronary atherosclerosis: an example of a transient phenotype.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2007)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
Dahkki: Siasos, G, et al.
Almmustuhtton: (2007)

Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2003)

Levosimendan: a novel agent in heart failure.
Dahkki: Koumallos, N, et al.
Almmustuhtton: (2006)

LOCAL ADIPONECTIN SYNTHESIS IN ADIPOSE TISSUE REGULATES VASCULAR SUPEROXIDE GENERATION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS: INSIGHTS BY USING FUNCTIONAL GENETIC POLYMORPHISMS OF ADIPONECTIN GENE
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2011)

Atorvastatin rapidly modifies vascular redox state and improves nitric oxide bioavailability in human vessels obtained from patients with advanced atherosclerosis
Dahkki: Demosthenous, M, et al.
Almmustuhtton: (2010)

5-Methyl-tetrahydrofolic acid rapidly improves endothelial function and superoxide production in human atherosclerosis: Effects on tetrahyd robiopterin-dependent eNOS coupling
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2006)

RAPID, DIRECT EFFECTS OF STATIN TREATMENT ON ARTERIAL REDOX STATE AND NITRIC OXIDE BIOAVAILABILITY IN HUMAN ATHEROSCLEROSIS VIA TETRAHYDROBIOPTERIN-MEDIATED ENOS COUPLING
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2011)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
Dahkki: Antonopoulos, A, et al.
Almmustuhtton: (2009)

Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
Dahkki: Tousoulis, D, et al.
Almmustuhtton: (2007)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2011)

A Novel Haplotype on GCH1 Gene, Encoding GTP Cyclohydrolase 1, Regulates Vascular Biopterin Synthesis, eNOS Coupling and Vascular Redox in Human Vessels
Dahkki: Antoniades, C, et al.
Almmustuhtton: (2008)